{"doi":"10.1101/2025.08.27.672709","title":"Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers","abstract":"Abstract The senescent cell (SC) fate is linked to aging, multiple disorders and diseases, and physical dysfunction. Senolytics, agents that selectively eliminate 30-70% of SCs, act by transiently disabling the senescent cell anti-apoptotic pathways (SCAPs), which defend those SCs that are pro-apoptotic and pro-inflammatory from their own senescence-associated secretory phenotype (SASP). Consistent with this, a JAK/STAT inhibitor, Ruxolitinib, which attenuates the pro-inflammatory SASP of senescent human preadipocytes, caused them to become “senolytic-resistant”. Administering senolytics to obese mice selectively decreased abundance of the subset of SCs that is pro-inflammatory. In cell cultures, the 30-70% of human senescent preadipocytes or human umbilical vein endothelial cells (HUVECs) that are senolytic-resistant (to Dasatinib or Quercetin, respectively) had increased p16 INK4a , p21 CIP1 , senescence-associated β-galactosidase (SAβgal), γH2AX, and proliferative arrest similarly to the total SC population (comprising senolytic-sensitive plus -resistant SCs). However, the SASP of senolytic-resistant SCs entailed less pro-inflammatory/ apoptotic factor production, induced less inflammation in non-senescent cells, and was equivalent or richer in growth/ fibrotic factors. Senolytic-resistant SCs released less mitochondrial DNA (mtDNA) and more highly expressed the anti-inflammatory immune evasion signal, glycoprotein non-melanoma-B (GPNMB). Transplanting senolytic-resistant SCs intraperitoneally into younger mice caused less physical dysfunction than transplanting the total SC population. Because Ruxolitinib attenuates SC release of pro-apoptotic SASP factors, while pathogen-associated molecular pattern factors (PAMPs) can amplify the release of these factors rapidly (acting as “senosensitizers”), senolytic-resistant and senolytic-sensitive SCs appear to be interconvertible.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2025,"id":573785,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9576,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1019916,"name":"Masayoshi Suda","orcid":"0000-0002-3415-6236","position":1,"is_corresponding":false},{"id":1371745,"name":"Vagisha Kulshreshtha","orcid":"0000-0002-2293-0749","position":2,"is_corresponding":false},{"id":1480942,"name":"Bryan Piatkowski","orcid":"0000-0002-1334-8431","position":3,"is_corresponding":false},{"id":268238,"name":"Allyson K. Palmer","orcid":"0000-0001-7505-3455","position":4,"is_corresponding":false},{"id":643304,"name":"Nino Giorgadze","orcid":null,"position":5,"is_corresponding":false},{"id":300038,"name":"Christina L. Inman","orcid":null,"position":6,"is_corresponding":false},{"id":616010,"name":"Nathan Gasek","orcid":"0000-0002-3501-6681","position":7,"is_corresponding":false},{"id":297894,"name":"Ming Xu","orcid":"0000-0002-4477-939X","position":8,"is_corresponding":false},{"id":617583,"name":"Kurt O. Johnson","orcid":"0000-0003-0682-4687","position":9,"is_corresponding":false},{"id":571781,"name":"Tamar Pirtskhalava","orcid":null,"position":10,"is_corresponding":false},{"id":787940,"name":"Selim Chaib","orcid":"0000-0003-0497-2002","position":11,"is_corresponding":false},{"id":626262,"name":"Larissa Prata","orcid":"0000-0001-9617-8089","position":12,"is_corresponding":false},{"id":255149,"name":"Yi Zhu","orcid":"0000-0002-3876-3156","position":13,"is_corresponding":false},{"id":539669,"name":"Renuka Kandhaya‐Pillai","orcid":"0000-0001-7571-7725","position":14,"is_corresponding":false},{"id":1481319,"name":"Tullius Stefan G","orcid":null,"position":15,"is_corresponding":false},{"id":1030736,"name":"Saranya P. Wyles","orcid":"0000-0002-0406-7427","position":16,"is_corresponding":false},{"id":1380321,"name":"Rambabu Majji","orcid":null,"position":17,"is_corresponding":false},{"id":288606,"name":"Hari Krishna Yalamanchili","orcid":"0000-0001-9892-3054","position":18,"is_corresponding":false},{"id":71621,"name":"David B. Allison","orcid":"0000-0003-3566-9399","position":19,"is_corresponding":false},{"id":106953,"name":"Tamar Tchkonia","orcid":"0000-0003-4623-7145","position":20,"is_corresponding":false},{"id":106952,"name":"James L. Kirkland","orcid":"0000-0003-1676-4905","position":21,"is_corresponding":false},{"id":1379698,"name":"Utkarsh Tripathi","orcid":"0000-0002-4994-629X","position":0,"is_corresponding":true}],"reference_count":59,"raw_metadata":null,"created_at":"2026-07-19T02:57:36.753600Z","pmid":"40909694","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}